Literature DB >> 22137774

European guidance: a project of the European Psychiatric Association.

W Gaebel1, H-J Möller.   

Abstract

Evidence based medicine is a cornerstone of modern medicine including psychiatry. Treatment practice guidelines are nowadays available for guiding mental health care mainly with a focus on specific disorders. Many important clinical situations or problems beyond treatment, however, are lacking proper guidance. It is in this scope that a European Psychiatry Association (EPA) has developed its own program, the European Guidance Project. The present special issue presents six topics out of these series of guidance documents.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Mesh:

Year:  2011        PMID: 22137774     DOI: 10.1016/j.eurpsy.2011.08.003

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  5 in total

1.  The EPA guidance document series.

Authors:  Wolfgang Gaebel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-03       Impact factor: 5.270

2.  European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia.

Authors:  Antonio Vita; Wolfgang Gaebel; Armida Mucci; Gabriele Sachs; Andreas Erfurth; Stefano Barlati; Federico Zanca; Giulia Maria Giordano; Louise Birkedal Glenthøj; Merete Nordentoft; Silvana Galderisi
Journal:  Eur Psychiatry       Date:  2022-09-05       Impact factor: 7.156

Review 3.  European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia.

Authors:  Antonio Vita; Wolfgang Gaebel; Armida Mucci; Gabriele Sachs; Stefano Barlati; Giulia Maria Giordano; Gabriele Nibbio; Merete Nordentoft; Til Wykes; Silvana Galderisi
Journal:  Eur Psychiatry       Date:  2022-09-05       Impact factor: 7.156

4.  EPA guidance on treatment of negative symptoms in schizophrenia.

Authors:  S Galderisi; S Kaiser; I Bitter; M Nordentoft; A Mucci; M Sabé; G M Giordano; M Ø Nielsen; L B Glenthøj; P Pezzella; P Falkai; S Dollfus; W Gaebel
Journal:  Eur Psychiatry       Date:  2021-03-17       Impact factor: 5.361

5.  EPA guidance on assessment of negative symptoms in schizophrenia.

Authors:  S Galderisi; A Mucci; S Dollfus; M Nordentoft; P Falkai; S Kaiser; G M Giordano; A Vandevelde; M Ø Nielsen; L B Glenthøj; M Sabé; P Pezzella; I Bitter; W Gaebel
Journal:  Eur Psychiatry       Date:  2021-02-18       Impact factor: 5.361

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.